{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T07:56:16Z","timestamp":1795247776358,"version":"4.10.3"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>ABSTRACT:<\/jats:title>\n                  <jats:p>There are three broad categories of hemostatic agents: 1) caustic, 2) physical, and 3) biologic. Because of the paucity of data on the use of topical hemostatic agents in gynecologic and obstetric surgery, indications for use are extrapolated from data on the use of these agents in other types of surgeries and are based on expert opinion. Topical hemostatic agents can be a useful adjunct to assist in the management of intraoperative bleeding in select circumstances. Topical hemostatic agents most commonly are used in situations where the use of electrocautery or sutures for hemostatic control of surgical bleeding is not ideal or safe, including bleeding in areas with nearby vulnerable structures or in the presence of diffuse bleeding from peritoneal surfaces or cut surfaces of solid organs. When managing intraoperative bleeding, there is no substitute for meticulous surgical technique. When possible, the surgeon should attempt to control intraoperative bleeding with sutures, clips, or electrosurgery before the use of hemostatic agents. It is essential for surgeons to understand the appropriate use, contraindications, and cost of these agents in order to make the most informed decision for patient care.<\/jats:p>","DOI":"10.1097\/aog.0000000000004104","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T23:15:41Z","timestamp":1600902941000},"page":"e81-e89","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":25,"title":["Topical Hemostatic Agents at Time of Obstetric and Gynecologic Surgery"],"prefix":"10.1097","volume":"136","member":"276","reference":[{"key":"R1-20261027","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1097\/AOG.0000000000002351","article-title":"Postpartum hemorrhage. Practice Bulletin No. 183. American College of Obstetricians and Gynecologists","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R2-20261027","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/AOG.0000000000003411","article-title":"Screening and management of bleeding disorders in adolescents with heavy menstrual bleeding. ACOG Committee Opinion No. 785. American College of Obstetricians and Gynecologists","volume":"134","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R3-20261027","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/01.AOG.0000438961.38979.19","article-title":"Von Willebrand disease in women. Committee Opinion No. 580. American College of Obstetricians and Gynecologists","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R4-20261027","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4103\/2229-5178.115509","article-title":"Achieving hemostasis in dermatology\u2014Part II: topical hemostatic agents","volume":"4","author":"Glick","year":"2013","journal-title":"Indian Dermatol Online J"},{"key":"R6-20261027","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.aorn.2011.09.018","article-title":"Achieving hemostasis with topical hemostats: making clinically and economically appropriate decisions in the surgical and trauma settings","volume":"94","author":"Schreiber","year":"2011","journal-title":"AORN J"},{"key":"R7-20261027","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/SLA.0b013e3181c3bcca","article-title":"A comprehensive review of topical hemostatic agents: efficacy and recommendations for use","volume":"251","author":"Achneck","year":"2010","journal-title":"Ann Surg"},{"key":"R8-20261027","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/archsurg.1972.04180010101027","article-title":"Compression of the brain and spinal cord following use of gelfoam","volume":"104","author":"Herndon","year":"1972","journal-title":"Arch Surg"},{"key":"R9-20261027","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1001\/archsurg.1956.01280010135018","article-title":"Complications from the use of absorbable hemostatic sponges","volume":"73","author":"Lindstrom","year":"1956","journal-title":"AMA Arch Surg"},{"key":"R10-20261027","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/OGX.0000000000000106","article-title":"Use of topical hemostatic agents in gynecologic surgery","volume":"69","author":"Wysham","year":"2014","journal-title":"Obstet Gynecol Surv"},{"key":"R11-20261027","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1245\/s10434-010-1059-3","article-title":"Risk of postoperative pelvic abscess in major gynecologic oncology surgery: one-year single-institution experience","volume":"17","author":"Fagotti","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R12-20261027","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10353-013-0222-z","article-title":"Comparison of regenerated and non-regenerated oxidized cellulose hemostatic agents","volume":"45","author":"Lewis","year":"2013","journal-title":"Eur Surg"},{"key":"R13-20261027","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.radcr.2015.08.002","article-title":"Intraovarian oxidized cellulose (Surgicel) mimicking acute ovarian pathology after recent pelvic surgery","volume":"10","author":"Zhang","year":"2015","journal-title":"Radiol Case Rep"},{"key":"R14-20261027","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/OGX.0b013e31816ff805","article-title":"Topical hemostatic agents in gynecologic surgery","volume":"63","author":"Duenas-Garcia","year":"2008","journal-title":"Obstet Gynecol Surv"},{"key":"R15-20261027","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/GRF.0000000000000147","article-title":"Management of hemorrhage during gynecologic surgery","volume":"58","author":"Yu","year":"2015","journal-title":"Clin Obstet Gynecol"},{"key":"R16-20261027","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jamcollsurg.2014.03.061","article-title":"Topical hemostatic therapy in surgery: bridging the knowledge and practice gap","volume":"219","author":"Shander","year":"2014","journal-title":"J Am Coll Surg"},{"key":"R17-20261027","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.aorn.2011.09.018","article-title":"Achieving hemostasis with topical hemostats: making clinically and economically appropriate decisions in the surgical and trauma settings","volume":"94","author":"Schreiber","year":"2011","journal-title":"AORN J"},{"key":"R19-20261027","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/1076029611404212","article-title":"A randomized trial of aprotinin-free fibrin sealant versus absorbable hemostat","volume":"17","author":"Fischer","year":"2011","journal-title":"Clin Appl Thromb Hemost"},{"key":"R20-20261027","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000072229","article-title":"A comparison of the haemostatic effect of Vivostat patient-derived fibrin sealant with oxidised cellulose (Surgicel) in multiple surgical procedures","volume":"35","author":"Hanks","year":"2003","journal-title":"Eur Surg Res"},{"key":"R21-20261027","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0022-5223(19)35324-3","article-title":"Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study","volume":"97","author":"Rousou","year":"1989","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R22-20261027","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/archsurg.139.11.1148","article-title":"Comparison of a new fibrin sealant with standard topical hemostatic agents","volume":"139","author":"Schwartz","year":"2004","journal-title":"Arch Surg"},{"key":"R24-20261027","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s10016-001-0073-0","article-title":"Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery","volume":"16","author":"Weaver","year":"2002","journal-title":"Ann Vasc Surg"},{"key":"R25-20261027","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0003-4975(00)01194-2","article-title":"Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group","volume":"69","author":"Oz","year":"2000","journal-title":"Ann Thorac Surg"},{"key":"R26-20261027","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1185\/030079908X273426","article-title":"Phase 3, randomized, double-blind study of plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing surgery","volume":"24","author":"Doria","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"R27-20261027","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jamcollsurg.2007.03.020","article-title":"A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis","volume":"205","author":"Chapman","year":"2007","journal-title":"J Am Coll Surg"},{"key":"R28-20261027","first-page":"301","article-title":"Effects of oxidized cellulose and microfibrillar collagen on infection","volume":"91","author":"Scher","year":"1982","journal-title":"Surgery"},{"key":"R29-20261027","first-page":"481","article-title":"Antibacterial activity of oxidized regenerated cellulose","volume":"142","author":"Dineen","year":"1976","journal-title":"Surg Gynecol Obstet"},{"key":"R30-20261027","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/109629603322419599","article-title":"In vitro antimicrobial activity of oxidized regenerated cellulose against antibiotic-resistant microorganisms","volume":"4","author":"Spangler","year":"2003","journal-title":"Surg Infect (Larchmt)"},{"key":"R31-20261027","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/AOG.0b013e318276ce3f","article-title":"Oxidized regenerated cellulose imitating pelvic abscess","volume":"121","author":"Behbehani","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R32-20261027","first-page":"1161","article-title":"An intraperitoneal tumorous mass caused by granulomas of microfibrillar collagen hemostat (Avitene)","volume":"119","author":"Nakajima","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"R33-20261027","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/02688699550041241","article-title":"A foreign body reaction to Surgicel(R) mimicking an abscess or tumour recurrence","volume":"9","author":"Buckley","year":"1995","journal-title":"Br J Neurosurg"},{"key":"R34-20261027","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.ajog.2008.10.052","article-title":"Eosinophil-rich inflammatory response to FloSeal hemostatic matrix presenting as postoperative pelvic pain","volume":"200","author":"Thomas","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"R35-20261027","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jmig.2010.03.021","article-title":"Pelvic inflammatory reactions to Floseal","volume":"18","author":"Carter","year":"2011","journal-title":"J Minim Invasive Gynecol"},{"key":"R36-20261027","first-page":"226","article-title":"Caseating granulomata caused by hemostatic agent posing as metastatic leiomyosarcoma","volume":"13","author":"Shashoua","year":"2009","journal-title":"JSLS"},{"key":"R37-20261027","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/ans.12784","article-title":"Appendicitis caused by gelatin-based haemostatic agent","volume":"86","author":"Teloken","year":"2016","journal-title":"ANZ J Surg"},{"key":"R38-20261027","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jmig.2010.03.024","article-title":"Small bowel obstruction associated with use of a gelatin-thrombin matrix sealant (FloSeal) after laparoscopic gynecologic surgery","volume":"17","author":"Suzuki","year":"2010","journal-title":"J Minim Invasive Gynecol"},{"key":"R39-20261027","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4293\/108680811X13125733356756","article-title":"Small bowel obstruction after FloSeal use","volume":"15","author":"Clapp","year":"2011","journal-title":"JSLS"},{"key":"R40-20261027","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jmig.2008.12.002","article-title":"Postoperative small bowel obstruction associated with use of hemostatic agents","volume":"16","author":"Hobday","year":"2009","journal-title":"J Minim Invasive Gynecol"},{"key":"R42-20261027","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1537-2995.2008.01717.x","article-title":"Estimating the pathogen safety of manufactured human plasma products: application to fibrin sealants and to thrombin","volume":"48","author":"Horowitz","year":"2008","journal-title":"Transfusion"},{"key":"R43-20261027","first-page":"1026","article-title":"Parvovirus infection after laparoscopic hysterectomy using fibrin glue hemostasis","volume":"95","author":"Morita","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R44-20261027","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1182\/blood.V76.10.2011.2011","article-title":"Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin","volume":"76","author":"Zehnder","year":"1990","journal-title":"Blood"},{"issue":"suppl 1","key":"R45-20261027","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1055\/s-2006-939559","article-title":"The clinical use and immunologic impact of thrombin in surgery","volume":"32","author":"Lawson","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"R47-20261027","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jvs.2008.01.034","article-title":"A comparison of recombinant thrombin to bovine thrombin as a hemostatic ancillary in patients undergoing peripheral arterial bypass and arteriovenous graft procedures","volume":"47","author":"Weaver","year":"2008","journal-title":"J Vasc Surg"},{"key":"R48-20261027","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1213\/ane.0b013e31817e6043","article-title":"Anaphylactic reaction after systemic application of aprotinin triggered by aprotinin-containing fibrin sealant","volume":"107","author":"Kober","year":"2008","journal-title":"Anesth Analg"},{"key":"R49-20261027","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/BF00311821","article-title":"How safe are the xenogeneic hemostats?\u2014Report of a case of severe systemic allergic reaction","volume":"25","author":"Kitamura","year":"1995","journal-title":"Surg Today"},{"key":"R50-20261027","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/bja\/aeq336","article-title":"Venous air embolism and intracardiac thrombus after pressurized fibrin glue during liver surgery","volume":"106","author":"Ebner","year":"2011","journal-title":"Br J Anaesth"},{"key":"R51-20261027","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/pan.12180","article-title":"Venous air embolism from Tisseel use during endoscopic cranial vault remodeling for craniosynostosis repair: a case report","volume":"23","author":"Felema","year":"2013","journal-title":"Paediatr Anaesth"},{"key":"R52-20261027","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1213\/ane.0b013e31818d3f48","article-title":"Thromboemboli, acute right heart failure and disseminated intravascular coagulation after intraoperative application of a topical hemostatic matrix","volume":"108","author":"Ferschl","year":"2009","journal-title":"Anesth Analg"},{"key":"R55-20261027","first-page":"654","article-title":"Providing hemostatic and blood conservation options for Jehovah's Witness patients in a large medical system","volume":"46","author":"Bai","year":"2016","journal-title":"Ann Clin Lab Sci"},{"key":"R56-20261027","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1472-6939-14-48","article-title":"Animal derived products may conflict with religious patients' beliefs","volume":"14","author":"Eriksson","year":"2013","journal-title":"BMC Med Ethics"}],"updated-by":[{"DOI":"10.1097\/aog.0000000000006132","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000}}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:01:53Z","timestamp":1793109713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004104"}},"subtitle":["ACOG Committee Opinion, Number 812"],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004104","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}